Antidepressants in bipolar disorder: The case for caution

Bipolar Disorders

Volumn 5, Issue 6, 2003, Pages 421-433

  Nassir Ghaemi, S ^a   Hsu, Douglas J ^a   Soldani, Federico ^a   Goodwin, Frederick K ^b  

^a CAMBRIDGE HOSPITAL   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Antidepressants; Bipolar disorder; Depression; Mood stabilizers; Psychopharmacology

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; LAMOTRIGINE; LITHIUM; MIRTAZAPINE; NEFAZODONE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE;

BIPOLAR DEPRESSION; BIPOLAR DISORDER; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; EMPIRICISM; EUROPE; GERMANY; HUMAN; MANIA; MOOD DISORDER; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SUICIDE; SUICIDE ATTEMPT;

AFFECT; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; DRUG THERAPY, COMBINATION; HUMANS; LITHIUM CARBONATE; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; RISK; TREATMENT OUTCOME;

EID: 0348077406     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1399-5618.2003.00074.x     Document Type: Review

References (83)

1. Sachs GS. Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. J Clin Psych-pharmacol 1996; 16 (Suppl. 1): 32S-47S.
2. Ghaemi SN, Ko JY, Goodwin FK. 'Cade's disease' and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder. Can J Psychiatry 2002; 47: 125-134.
3. Yatham LN, Kusumakar V, Parikh SV et al. Bipolar depression: treatment options. Can J Psychiatry 1997; 42: 87S-91S.
4. Kusumakar V, Yatham LN, Haslam DRS et al. Treatment of mania, mixed state, and rapid cycling. Can J Psychiatry 1997; 42: 79S-86S.
5. Bauer M, Callahan A, Jampala C et al. Clinical practice guidelines for bipolar disorder from the department of veterans affairs. J Clin Psychiatry 1999; 60: 9-21.
6. Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty JP. The Expert Consensus Guideline Series: medication treatment of bipolar disorder 2000. Postgraduate Med 2000; Spec: 1-104.
7. Kahn DA, Sachs GS, Printz DJ, Carpenter D, Docherty JP, Ross R. Expert consensus guidelines for the medication treatment of bipolar disorder: a new treatment tool. TEN 2001; 3: 49-57.
8. Hirschfeld RMA, Bowden CL, Gitlin MJ et al. American Psychiatric Association practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002; 159 (Suppl.): 1-50.
9. Moller H-J, Grunze H. Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? Eur Arch Psychiatry Clin Neurosci 2000; 250: 57-68.
10. Tondo L, Hennen J, Baldessarini RJ. Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr Scand 2001; 104: 163-172.
11. Rothman K, Greenland S. Modern Epidemiology. Philadelphia, PA: Lippincott-Raven 1998; xiii: 737.
12. Cohn JB, Collins G, Ashbrook E, Wernick JF. A comparison of fluoxetine, imipramine and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol 1989; 4: 313-314.
13. Nemeroff CB, Evans DL, Gyulai L et al. Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 2001; 158: 906-912.
14. Young LT, Joffe RT, Robb JC, MacQueen GM, Marriott M, Patells-Siotis I. Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am J Psychiatry 2000; 157: 124-126.
15. Sachs GS, Lafer B, Stoll AL et al. A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry 1994; 55: 391-393.
16. Vieta E, Martinez-Aran A, Goikolea JM et al. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. J Clin Psychiatry 2002; 63: 508-512.
17. Goodwin FK, Jamison KR. Manic Depressive Illness. New York: Oxford University Press, 1990.
18. Peet M. Induction of mania with selective serotonin reuptake inhibitors and tricyclic antidepressants. Br J Psychiatry 1994; 164: 549-550.
19. Amsterdam JD, Garcia-Espana F, Fawcett J et al. Efficacy and safety of fluoxetine in treating bipolar II major depressive episode. J Clin Psychopharmacol 1998; 18: 435-440.
20. Amsterdam JD, Garcia-Espana F. Venlafaxine monotherapy in women with bipolar II and unipolar major depression. J Affect Disord 2000; 59: 225-229.
21. Goldberg J, Whiteside J. The association between substance abuse and antidepressant-induced mania in bipolar disorder: a preliminary study. J Clin Psychiatry 2002; 63: 791-795.
22. Boerlin H, Gitlin M, Zoellner L, Hammen C. Bipolar depression and antidepressant-induced mania: a naturalistic study. J Clin Psychiatry 1998; 59: 374-379.
23. Bottlender R, Rudolf D, Strauss A, Moller H. Antidepressant-associated maniform states in acute treatment of patients with bipolar-I depression. Eur Arch Psychiatry Clin Neurosci 1998; 248: 296-300.
24. Henry C, Sorbara F, Lacoste J, Gindre C, Leboyer M. Antidepressant-induced mania in bipolar patients: identification of risk factors. J Clin Psychiatry 2001; 62: 249-255.
25. Rosenquist K, Ghaemi S, Ko J, Goodwin F, Baldessarini R. Effects of Newer and Older Antidepressants in Bipolar Depression. Annual Meeting of the American Psychiatric Association. San Francisco, CA: American Psychiatric Association, 2003.
26. Quitkin FM, Kane J, Rifkin A, Ramos-Lorenzi JR, Nayak DV. Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. Arch Gen Psychiatry 1981; 38: 902-907.
27. Wehr T, Goodwin F. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry 1979; 36: 555-559.
28. Wehr TA, Sack DA, Rosenthal NE, Cowdry RW. Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry 1988; 145: 179-184.
29. Kukopulos A, Reginaldi P, Laddomada G, Floris G, Serra G, Tondo L. Course of the manic-depressive cycle and changes caused by treatments. Pharmakopsychiat 1980; 13: 156-167.
30. Kukopulos A. The Role of Antidepressant Treatments in Rapid-Cycling (Abstract). 2nd International Conference on Bipolar Disorder. Pittsburgh, PA: 1997.
31. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995; 152: 1130-1138.
32. Ghaemi SN, Boiman EE, Goodwin FK. Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. J Clin Psychiatry 2000; 61: 804-808.
33. Ghaemi SN, Rosenquist KJ, Ko JY, Baldassano CF, Kontos NJ, Baldessarini RJ. Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry 2003; in press.
34. Angst J. Switch from depression to mania - a record study over decades between 1920 and 1982. Psychopathology 1985; 18: 140-154.
35. Lewis JL, Winokur G. The induction of mania: a natural history study with controls. Arch Gen Psychiatry 1982; 39: 303-306.
36. Kupfer DJ, Carpenter LL, Frank E. Possible role of antidepressants in precipitating mania and hypomania in recurrent depression. Am J Psychiatry 1988; 145: 804-808.
37. Turvey CL, Coryell WH, Solomon DA et al. Long-term prognosis of bipolar I disorder. Acta Psychiatr Scand 1999; 99: 110-119.
38. Altshuler LL, Kiriakos L, Calcagno J et al. The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review. J Clin Psychiatry 2001; 62: 612-616.
39. Prien RF, Kupfer DJ, Mansky PA et al. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders: a report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry 1984; 41: 1096-1104.
40. Bostwick JM, Pankratz VS. Affective disorders and suicide risk: a reexamination. Am J Psychiatry 2000; 157: 1925-1932.
41. Khan A, Warner HA, Brown WA. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. Arch Gen Psychiatry 2000; 57: 311-317.
42. Khan A, Khan SR, Leventhal RM, Brown WA. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database. Int J Neuropsychopharmacol 2001; 4: 113-118.
43. Montgomery S, Dunner D, Dunbar G. Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. Eur Neuropsychopharmacol 1995; 5: 5-13.
44. Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 2002; 68: 167-181.
45. Goldberg J, Garno J, Leon A, Kocsis J, Portera L. Association of recurrent suicidal ideation with nonremission from acute mixed mania. Am J Psychiatry 1998; 155: 1753-1755.
46. Akiskal H. The milder spectrum of bipolar disorders: diagnostic, characterologic and pharmacologic aspects. Psychiatr Annals 1987; 17: 32-37.
47. Akiskal HS, Mallya G. Criteria for the "soft" bipolar spectrum: treatment implications. Psychopharmacol Bull 1987; 23: 68-73.
48. Koukopoulos A, Faedda G, Proietti R, D'Amico S, de Pisa E, Simonetto C. Mixed depressive syndrome. Encephale 1992; 18 (Spec No 1): 19-21.
49. McElroy SL, Keck PE, Pope HG, Hudson JI, Faedda GL, Swann AC. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry 1992; 149: 1633-1644.
50. Goodwin F. Rationale for long-term treatment of bipolar disorder and evidence for long-term lithium treatment. J Clin Psychiatry 2002; 63 (Suppl.): 5-12.
51. Fieve RR, Platman SR, Plutchik RR. The use of lithium in affective disorders: I. Acute endogenous depression. Am J Psychiatry 1968; 125: 487-491.
52. Mendels J, Secunda SK, Dyson WL. A controlled study of the antidepressant effects of lithium carbonate. Arch Gen Psychiatry 1972; 26: 154-157.
53. Watanabe S, Ishino H, Otsuki S. Double-blind comparison of lithium carbonate and imipramine in the treatment of depression. Arch Gen Psychiatry 1975; 32: 659-668.
54. Worrall EP, Moody JP, Peet M et al. Controlled studies of the acute antidepressant effects of lithium. Brit J Psychiatry 1979; 135: 255-262.
55. Calabrese J, Bowden C, Mee-Lee D et al. Lamotrigine or Lithium in the Maintenance Treatment of Bipolar I Disorder. Annual meeting of the American Psychiatric Association. Philadelphia, PA: American Psychiatric Association, 2002.
56. Ghaemi SN, Lenox ML, Baldessarini RJ. Effectiveness and safety of antidepressants in long-term treatment of bipolar disorder. J Clin Psychiatry 2001; 62: 565-569.
57. Prien RF, Klett CJ, Caffey EM. Lithium carbonate and imipramine in prevention of affective episodes: a comparison in recurrent affective illness. Arch Gen Psychiatry 1973; 29: 420-425.
58. Kane JM, Quitkin FM, Rifkin A, Ramos-Lorenzi JR, Nayak DD, Howard A. Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison. Arch Gen Psychiatry 1982; 39: 1065-1069.
59. Zornberg G, Pope HJ. Treatment of depression in bipolar disorder: new directions for research. J Clin Psychopharmacol 1993; 13: 397-408.
60. Goodwin FK, Murphy DL, Dunner DL, Bunney WE. Lithium response in unipolar versus bipolar depression. Amer J Psychiatry 1972; 129: 44-47.
61. Noyes R, Dempsey GM, Blum A, Cavanaugh GL. Lithium treatment of depression. Compr Psychiatry 1974; 15: 187-193.
62. Mendels J. Lithium in the treatment of depression. Am J Psychiatry 1976; 133: 373-378.
63. Baron M, Gershon ES, Rudy V, Jonas WZ, Buchsbaum M. Lithium carbonate response in depression. Arch Gen Psychiatry 1975; 32: 1107-1111.
64. Sachs G, Altshuler L, Kelter T et al. Divalproex Versus Placebo for the Treatment of Bipolar Depression. Annual meeting of the American College of Neuropsychopharmacology. Puerto Rico: American College of Neuropsychopharmacology, 2001.
65. Petty F, Kram M, Davis L et al. Valproate treatment of bipolar depression. 39th Annual New Clinical Drug Evaluation Unit Meeting (NCDEU). Boca Raton, FL, 1999.
66. Ghaemi SN, Goodwin FK. Long-term naturalistic treatment of depressive symptoms in bipolar illness with divalproex vs. lithium in the setting of minimal antidepressant use. J Affect Disord 2001; 65: 281-287.
67. Ballenger JC, Post RM. Therapeutic effects of carbamazepine in affective illness: a preliminary report. Commun Psychopharmacol 1978; 2: 159-175.
68. Post RM, Uhde TW, Ballenger JC, Chatterji DC, Greene RF, Bunney WE Jr. Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant response. Arch Gen Psychiatry 1983; 40: 673-676.
69. Kramlinger KG, Post RM. The addition of lithium to carbamazepine. Antidepressant efficacy in treatment-resistant depression. Arch Gen Psychiatry 1989; 46: 794-800.
70. Calabrese J, Bowden C, Sachs G, Ascher J, Monaghan E, Rudd G. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999; 60: 79-88.
71. Frye MA, Ketter TA, Kimbrell TA et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000; 20: 607-614.
72. Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G. Lithium maintenance treatment of mood disorders (Cochrane Review). The Cochrane Library. Oxford: Update Software, 2002.
73. Suppes T, Baldessarini RJ, Faedda GL, Tohen M. Risk of reoccurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry 1991; 48: 1082-1088.
74. Baldessarini R, Tondo L. Does lithium treatment still work? Evidence of stable responses over three decades. Arch Gen Psychiatry 2000; 57: 187-190.
75. Bowden C, Calabrese J, McElroy S et al. A randomized, placebo-controlled 12-month rial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry 2000; 57: 481-489.
76. Bowden CL, Calabrese JR, Sachs G et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003; 60: 392-400.
77. Calabrese JR, Bowden CL, Sachs GS et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003; 64: 1013-1024.
78. Lambert P, Venaud G. Comparative study of valpromide vs lithium in treatment of affective disorders. Nervure 1992; 5: 57-65.
79. Hirschfeld RM, Allen MH, McEvoy JP, Keck PE Jr, Russell JM. Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. J Clin Psychiatry 1999; 60: 815-818.
80. Okuma T, Inanaga K, Otsuki S et al. A preliminary study double-blind study on the the efficacy of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacol 1981; 73: 95-96.
81. Watkins SE, Callender K, Thomas DR, Tidmarsh SF, Shaw DM. The effect of carbamazepine and lithium on remission from affective illness. Br J Psychiatry 1987; 150: 180-182.
82. Lusznat R, Murphy D, Nunn C. Carbamazepine vs lithium in the treatment and prophylaxis of mania. Br J Psychiatry 1988; 153: 198-204.
83. Ghaemi SN, Sachs GS, Chiou AM, Pandurangi AK, Goodwin FK. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? J Affect Disord 1999; 52: 135-144.